Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032044 · ClinicalTrials.gov registry record · NA
CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
A NA study, sponsored by Mauna Kea Technologies.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT01032044 is a NA study that has completed, run by Mauna Kea Technologies. The registered enrollment target is 164 participants.
The verdict
NCT01032044, a NA study, has completed, sponsored by Mauna Kea Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
This study focuses on demonstrating the value of probe-based Confocal Laser Endomicroscopy (pCLE) in guiding endoscopic therapeutic procedures in Barrett's Esophagus (BE). It is a randomized controlled outcomes study including patients already treated for Barrett's Esophagus lesion(s) and undergoing high definition white light endoscopy follow up procedure, with or without pCLE (2 arms will be considered in this study). The procedures will be carried out per standards of practice with appropriately trained physicians.
Interventions
- DEVICE Standard endoscopic evaluation
- DEVICE pCLE guided evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01032044
The ClinicalTrials.gov registry entry for NCT01032044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mauna Kea Technologies, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard endoscopic evaluation is the first listed.
NCT01032044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01032044 about?
NCT01032044 is a clinical study titled "CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia". This study focuses on demonstrating the value of probe-based Confocal Laser Endomicroscopy (pCLE) in guiding endoscopic therapeutic procedures in Barrett's Esophagus (BE). It is a randomized controlled outcomes study including patients already treated for Barrett's Esophagus lesion(s) and undergoin...
What is the current status of trial NCT01032044?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2010-02. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01032044?
The interventions under investigation include: Standard endoscopic evaluation (DEVICE), pCLE guided evaluation (DEVICE).
Who is sponsoring clinical trial NCT01032044?
This trial is sponsored by Mauna Kea Technologies, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.